Navigation Links
Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
Date:10/18/2011

SEATTLE, Oct. 18, 2011 /PRNewswire/ -- Immune Design Corp. (IDC) announced today that Guy F. Cipriani, MBA will be joining the company as its new Chief Business Officer.  In the position, Mr. Cipriani will leverage more than 12 years of pharmaceutical and biotechnology industry experience to lead strategy and business development activities for the company's rapidly advancing pipeline of novel therapeutic vaccines and immunotherapies for infectious diseases, cancer and allergy.

(Logo:  http://photos.prnewswire.com/prnh/20111018/SF88252LOGO)

Most recently, he was Vice President of Business Development and a member of senior management at Cardiome Pharma Corp. in Vancouver, B.C. Canada.  Prior to Cardiome, Mr. Cipriani served as Director of Business Development for TransForm Pharmaceuticals, Inc., a biotechnology company based in Lexington, MA, that was acquired by Johnson and Johnson in April 2005. He also spent 5 years in Corporate Business Development at Eli Lilly and Company in Indianapolis, IN, and previously as a management consultant with Accenture in Chicago, IL.  Mr. Cipriani received his MBA from the Kellogg School of Management at Northwestern University and holds a B.S.E.E., High Honors from Rochester Institute of Technology.

"We are pleased to welcome Guy to our senior management team, as he is an extraordinary individual with great experience.  His demonstrated success in both biotechnology and pharmaceutical companies will be of significant value to IDC as we pursue new collaborations around our two platforms and broad strategic partnerships," said Carlos V. Paya. MD, Ph.D., Chief Executive Officer of IDC.

Mr. Cipriani commented, "I am excited to join an organization with such talented scientists and promising technologies.  I believe that IDC's platforms have tremendous partnering potential and that they can be leveraged in transactions that allow the company to advance aggressively.  I look forward to playing a key role on the senior management team as we take the company forward."

About Immune Design Corp.

Immune Design Corp. is a privately held, clinical-stage biotechnology company based in Seattle, Washington and formed in 2008 to bring together some of the world's leaders in the field of molecular immunology to develop vaccines for the treatment and prevention of infectious and malignant disease.  The company employs advanced and leading edge methods to precisely control the activation and context of antigen presentation by dendritic cells in order to shape the desired adaptive immune response.  This goal is accomplished through the application of two proprietary technology platforms that activate the immune system by distinct mechanisms.

Additional information can be found on the company's website at www.immunedesign.com.

Contact Media:
Cassie Ostrander 206-826-7901 or media@immunedesign.com


'/>"/>
SOURCE Immune Design Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Alcohol-related behavior changes -- blame your immune system
2. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
3. New HIV vaccine approach targets desirable immune cells
4. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
5. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
6. UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs
7. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
8. NIH scientists show how anthrax bacteria impair immune response
9. Immune Design Grants Adjuvant License to MedImmune
10. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
11. Major disease-vector mosquito reveals the secrets of its immune system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Netherlands (PRWEB) , ... April 20, 2017 , ... ... Technology today announced their strategic partnership to offer a full spectrum of ... authentication, a comprehensive suite of biometric products and the ground-breaking proactive cybersecurity services ...
(Date:4/20/2017)... , April 20, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: ... results at the International Liver Congress ("ILC") 2017 of the ... Amsterdam on the positive effects of ... model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President of R&D ...
(Date:4/20/2017)... and PETACH TIKVAH, Israel , April 20, ... developer of adult stem cell technologies for neurodegenerative diseases, announced ... present at the Alliance for Regenerative Medicine,s (ARM) 5 th ... April 27, 2017 at 09:40 EDT in Boston ... , MD, MHSc, Chief Medical Officer & Chief Operating Officer, ...
(Date:4/19/2017)... ... 2017 , ... Optofluidics today announced that it's changing its ... changed focus to making analytical tools for biopharmaceutical quality control. “We are excited ... Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):